UPSTREAM BIO INC. - COMMON STOCK

Upstream Bio Reports Second Quarter 2025 Financial Results and Highlights Continued Progress

06 8月 2025 04:00:00 条件 Nasdaq GlobeNewswire

Upstream Bio Announces First Patient Dosed in Phase 2 Clinical Trial of Verekitug in Chronic Obstructive Pulmonary Disease (COPD)

08 7月 2025 04:00:00 条件 Nasdaq GlobeNewswire

Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP Receptor

15 6月 2025 04:45:00 条件 Nasdaq GlobeNewswire

Upstream Bio to Present Mechanistic Insights into Verekitug’s Enhanced Potency via TSLP Receptor Targeting at European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025

05 6月 2025 04:00:00 条件 Nasdaq GlobeNewswire

Upstream Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

04 6月 2025 04:00:00 条件 Nasdaq GlobeNewswire

Upstream Bio Appoints Stacy Price as Chief Technology Officer

20 5月 2025 04:00:00 条件 Nasdaq GlobeNewswire

Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs

06 5月 2025 04:00:00 条件 Nasdaq GlobeNewswire

Upstream Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

12 3月 2025 04:00:00 条件 Nasdaq GlobeNewswire

Upstream Bio to Present at Upcoming March Investor Conferences

25 2月 2025 05:00:01 条件 Nasdaq GlobeNewswire

Upstream Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference

06 1月 2025 05:00:01 条件 Nasdaq GlobeNewswire

Upstream Bio Appoints Allison Ambrose as General Counsel

17 12月 2024 05:00:00 条件 Nasdaq GlobeNewswire

Upstream Bio Announces Addition to Russell 2000® Index

16 12月 2024 05:00:04 条件 Nasdaq GlobeNewswire

Upstream Bio to Participate in the Piper Sandler 36th Annual Healthcare Conference

21 11月 2024 05:00:00 条件 Nasdaq GlobeNewswire

Upstream Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights

07 11月 2024 04:00:01 条件 Nasdaq GlobeNewswire

Upstream Bio Announces Closing of $293 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

15 10月 2024 13:15:00 条件 Nasdaq GlobeNewswire